Homologous recombination deficiency is common in ovarian cancer.5 Approximately 1-in-2 women with advanced ovarian cancer have HRD-positive tumours (including those with a tBRCAm).5-7
Learn how to request a HRD test.
Homologous recombination deficiency is common in ovarian cancer.5 Approximately 1-in-2 women with advanced ovarian cancer have HRD-positive tumours (including those with a tBRCAm).5-7
Learn how to request a HRD test.